Literature DB >> 10230683

Characteristics of male hip fracture patients.

J Huuskonen1, H Kröger, I Arnala, E Alhava.   

Abstract

BACKGROUND AND AIMS: Among men, hip fracture is the most common outcome of osteoporosis. The aim of this study was to investigate the clinical characteristics, treatment, complications, short-term outcome and mortality of male hip fracture patients.
MATERIAL AND METHODS: Operation theatre logs of all hip fracture patients operated on (1124 patients) at Kuopio University Hospital in 1989-1993 were reviewed. Medical records of the 276 male patients who underwent surgery (25 % of all patients) were studied. RESULTS AND
CONCLUSIONS: 233 hip fractures (86 %) in men were due to low energy trauma. Of these cases, 61 % of the fractures occurred at the femoral neck, 31 % were pertrochanteric and 8 % subtrochanteric. The vast majority (90 %) of these patients had some chronic medical condition, and in 66 % the condition influenced motory or sensory functions. Hemiarthroplasty was most often used for femoral neck fractures (64 %). Internal fixation was used for pertrochanteric (97 %) and subtrochanteric (94 %) fractures. 20 % of the men had post-operative complications during the 1.5 year follow-up. During primary hospitalisation mortality was 3 %. Within 1.5 years of the fracture 40 % of the men had died, resulting in a mortality three times higher than age matched Finnish male population.

Entities:  

Mesh:

Year:  1999        PMID: 10230683

Source DB:  PubMed          Journal:  Ann Chir Gynaecol        ISSN: 0355-9521


  2 in total

1.  Comparing the bone mineral density among male patients with latent autoimmune diabetes and classical type 1 and type 2 diabetes, and exploring risk factors for osteoporosis.

Authors:  M Zhang; C Sheng; H You; M Cai; J Gao; X Cheng; H Sheng; S Qu
Journal:  J Endocrinol Invest       Date:  2021-01-02       Impact factor: 4.256

2.  Temporal trends in hip fracture incidence, mortality, and morbidity in Denmark from 1999 to 2012.

Authors:  Christopher Jantzen; Christian M Madsen; Jes B Lauritzen; Henrik L Jørgensen
Journal:  Acta Orthop       Date:  2018-02-01       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.